FIN 0.00% $1.13 finzsoft solutions limited

Ann: SSH: FIN: SSH Notice - Silverlake HGH Limited

  1. lightbulb Created with Sketch. 2
    					FIN
    23/03/2015 08:35
    SSH
    NOT PRICE SENSITIVE
    REL: 0835 HRS Finzsoft Solutions Limited
    
    SSH: FIN: SSH Notice - Silverlake HGH Limited
    
    Disclosure of movement of 1% or more in substantial holding
    or change in nature of relevant interest, or both
    Sections 277 and 278, Financial Markets Conduct Act 2013
    
    To  NZX Limited
    and
    To  Finzsoft Solutions Limited ("Finzsoft")
    
    Relevant event being disclosed:  Movement of 1% or more in substantial
    holding and change in nature of relevant interest
    Date of relevant event: 20 March 2015
    Date this disclosure made: 20 March 2015
    Date last disclosure made: 17 March 2015
    
    Substantial product holder(s) giving disclosure
    Full name: Silverlake HGH Limited ("Silverlake HGH")
    
    Summary of substantial holding
    Class of quoted voting products: Ordinary shares in Finzsoft (NZX:FIN)
    Summary for: Silverlake HGH
    For this disclosure,--
    (a) total number held in class: 6,610,719
    (b) total in class: 8,566,164
    (c) total percentage held in class: 77.172%
    For last disclosure,--
    (a) total number held in class: 6,608,719
    (b) total in class: 8,566,164
    (c) total percentage held in class: 77.149%
    
    Details of transactions and events giving rise to relevant event
    On 27 February 2015, Silverlake HGH made a full takeover offer for all of the
    ordinary shares and other equity securities in Finzsoft (the "Offer"). The
    Offer price for the ordinary shares in Finzsoft is $3.00 per share. Under the
    Offer, legal and beneficial ownership to shares which are accepted into the
    Offer transfers to Silverlake HGH on payment for those shares. A copy of the
    Offer document was sent to NZX on 27 February 2015.
    Since the last disclosure dated 17 March 2015, Silverlake HGH has received an
    additional acceptance to the Offer for a further 2,000 ordinary shares in
    Finzsoft.
    On 20 March 2015, Silverlake HGH purchased 156,250 ordinary shares in
    Finzsoft under the Offer (being the "Acceptance Shares" described in the last
    disclosure dated 17 March 2015), and therefore became the legal and
    beneficial owner of those 156,250 ordinary shares.
    As at the time of this notice, Silverlake HGH has a relevant interest in
    6,610,719 ordinary shares in Finzsoft (representing 77.172% of all of the
    ordinary shares in Finzsoft) as follows:
    - 6,608,719 ordinary shares (representing 77.149% of all of the ordinary
    shares in Finzsoft), being shares which are legally and beneficially owned by
    Silverlake HGH; and
    - 2,000 ordinary shares (representing 0.023% of all of the ordinary shares in
    Finzsoft), being shares for which Silverlake HGH has received acceptances to
    the Offer, but which have not yet been paid for under the Offer.
    
    Details after relevant event
    Details for:  Silverlake HGH
    Nature of relevant interest(s):  Registered holder and beneficial owner of
    ordinary shares in Finzsoft
    For that relevant interest,--
    (a) number held in class: 6,608,719
    (b) percentage held in class: 77.149%
    (c) current registered holder(s): Silverlake HGH
    (d) registered holder(s) once
    transfers are registered: Not applicable
    Details after relevant event
    Details for:  Silverlake HGH
    Nature of relevant interest(s): Power to control the acquisition of ordinary
    shares in Finzsoft, on payment of the Offer price for those shares
    For that relevant interest,--
    (a) number held in class: 2,000
    (b) percentage held in class: 0.023%
    (c) current registered holder(s): Arthur Tait Garlick
    (d) registered holder(s) once
    transfers are registered: Silverlake HGH
    Additional information
    Address of substantial product holder: 26-01/04, 143 Cecil Street, GB
    Building, Singapore 069542
    Contact details: Kwong Yong Sin
    +603 7721 6118
    [email protected]
    Name of any other person believed to have given, or believed to be required
    to give, a disclosure under the Financial Markets Conduct Act 2013 in
    relation to the financial products to which this disclosure relates: HGH (ICT
    Investments No. 2) Limited and Silverlake Axis Ltd.
    
    Certification
    I, Nathanael William Starrenburg, certify that, to the best of my knowledge
    and belief, the information contained in this disclosure is correct and that
    I am duly authorised to make this disclosure by all persons for whom it is
    made.
    End CA:00262142 For:FIN    Type:SSH        Time:2015-03-23 08:35:07
    				
 
watchlist Created with Sketch. Add FIN (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.